MOCA Health: Supplying GMP-Certified Medical Cannabis to the United States
Medicinal Organic Cannabis Australia (MOCA) Pty Ltd is a leading supplier of GMP-certified, pharmaceutical-grade medical cannabis. With full export licensing from the Australian Office of Drug Control, MOCA specializes in delivering high-quality cannabis products to international markets, including the United States.
The United States is home to one of the world’s largest and most dynamic medical cannabis industries. With over 40 states legalizing medical cannabis, the demand for pharmaceutical-grade cannabis products continues to rise. The U.S. medical cannabis market is projected to surpass $12 billion by 2025, driven by increasing patient access and ongoing regulatory advancements.
MOCA ensures the highest standards in cannabis cultivation, processing, and distribution. Our medical cannabis products are:
GMP-Certified: Produced under Good Manufacturing Practice (GMP) standards to ensure pharmaceutical-grade consistency and safety.
TGA-Compliant: Meeting strict Australian Therapeutic Goods Administration (TGA) guidelines, aligning with international regulatory requirements.
Third-Party Tested: Rigorously tested for potency, purity, and contaminants to guarantee product safety and efficacy.
MOCA supplies a variety of high-quality medical cannabis products tailored for the U.S. market. Our offerings include:
Premium Cannabis Flower: Australian-grown, GMP-certified flower in various THC and CBD formulations.
Cannabis Oils and Tinctures: Precision-formulated liquid extracts for controlled therapeutic use.
Isolated Cannabinoid Products: 99.9% pure CBD isolate and other refined cannabinoids for pharmaceutical applications.
Reliable, Scalable Supply: MOCA provides a consistent and scalable cannabis supply chain for U.S. distributors and healthcare providers.
Pharmaceutical-Grade Standards: Our GMP-certified products meet the highest safety and quality standards.
Regulatory Compliance Expertise: With extensive knowledge of global cannabis regulations, MOCA ensures seamless compliance with U.S. import and distribution laws.
Customizable Product Solutions: We offer tailored formulations to meet specific therapeutic needs and patient requirements.
Sustainability-Focused Production: MOCA prioritizes ethical and environmentally responsible cultivation and manufacturing practices.
MOCA works closely with U.S. pharmaceutical distributors, healthcare institutions, and regulatory agencies to facilitate smooth entry into the market. We provide comprehensive compliance documentation, including Certificates of Analysis (COA) and GMP certifications, to streamline regulatory approvals.
As the U.S. medical cannabis industry expands, MOCA remains committed to supplying high-quality, pharmaceutical-grade cannabis products to improve patient care and treatment options.
MOCA is actively seeking partnerships with U.S.-based distributors, healthcare providers, and pharmaceutical companies looking to integrate premium, GMP-certified medical cannabis into their offerings.
For inquiries regarding bulk supply, regulatory guidance, or customized product solutions, contact our international sales team today.